Robert Pilarski

46.8k total citations · 1 hit paper
62 papers, 3.6k citations indexed

About

Robert Pilarski is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Robert Pilarski has authored 62 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 22 papers in Genetics and 18 papers in Cancer Research. Recurrent topics in Robert Pilarski's work include BRCA gene mutations in cancer (16 papers), PI3K/AKT/mTOR signaling in cancer (14 papers) and Cancer Genomics and Diagnostics (12 papers). Robert Pilarski is often cited by papers focused on BRCA gene mutations in cancer (16 papers), PI3K/AKT/mTOR signaling in cancer (14 papers) and Cancer Genomics and Diagnostics (12 papers). Robert Pilarski collaborates with scholars based in United States, Egypt and United Kingdom. Robert Pilarski's co-authors include Mohamed H. Abdel‐Rahman, Charis Eng, Colleen M. Cebulla, Frederick H. Davidorf, James B. Massengill, Kristen M. Shannon, Lana N. Pho, R. Burt, E. Swisher and Karan Rai and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Robert Pilarski

59 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations

2005 592 citations Robert Pilarski, Charis Eng et al. Journal of Medical Genetics profile →

Peers

Robert Pilarski

GENET

ONCOL

PFM

Shirley Hodgson United Kingdom

John R.W. Yates United Kingdom

Alfons Meindl Germany

Ludwine Messiaen United States

Daniel C. Chung United States

Masataka Ohta United States

Adam Shlien Canada

Jessica L. Mester United States

Timothy T. Stenzel United States

Claudia Ruivenkamp Netherlands

Shirley Hodgson United Kingdom

Robert Pilarski

1.7k ×0.9

1.3k ×1.2

GENET

791 ×0.8

ONCOL

469 ×0.8

574 ×1.1

PFM

Citations per year, relative to Robert Pilarski Robert Pilarski (= 1×) peers Shirley Hodgson

Countries citing papers authored by Robert Pilarski

Since Specialization

Citations

This map shows the geographic impact of Robert Pilarski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Pilarski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Pilarski more than expected).

Fields of papers citing papers by Robert Pilarski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Pilarski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Pilarski. The network helps show where Robert Pilarski may publish in the future.

Co-authorship network of co-authors of Robert Pilarski

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Pilarski. A scholar is included among the top collaborators of Robert Pilarski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Pilarski. Robert Pilarski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pilarski, Robert, et al.. (2021). Genetic evaluation of patients and families with concern for hereditary endocrine tumor syndromes. Familial Cancer. 21(1). 93–100. 1 indexed citations

Ferguson, Robert, Matjaž Vogelsang, Karan Rai, et al.. (2016). Genetic markers of pigmentation are novel risk loci for uveal melanoma. Scientific Reports. 6(1). 31191–31191. 30 indexed citations

Reinbolt, Raquel E., Roshan M. Patel, Xueliang Pan, et al.. (2015). Risk factors for anthracycline-associated cardiotoxicity. Supportive Care in Cancer. 24(5). 2173–2180. 39 indexed citations

Cebulla, Colleen M., Elaine M. Binkley, Robert Pilarski, et al.. (2015). Analysis ofBAP1Germline Gene Mutation in Young Uveal Melanoma Patients. Ophthalmic Genetics. 36(2). 126–131. 26 indexed citations

Jin, Ming, Heather Hampel, Robert Pilarski, et al.. (2013). Phosphatase and Tensin Homolog Immunohistochemical Staining and Clinical Criteria for Cowden Syndrome in Patients With Trichilemmoma or Associated Lesions. American Journal of Dermatopathology. 35(6). 637–640. 11 indexed citations

Pilarski, Robert, et al.. (2013). Cowden Syndrome and the PTEN Hamartoma Tumor Syndrome: Systematic Review and Revised Diagnostic Criteria. JNCI Journal of the National Cancer Institute. 105(21). 1607–1616. 357 indexed citations

Pilarski, Robert, Divya A. Patel, Jeffrey N. Weitzel, et al.. (2012). The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian Cancer. PLoS ONE. 7(5). e37891–e37891. 27 indexed citations

Kais, Zeina, Sanford H. Barsky, Haritha Mathsyaraja, et al.. (2011). KIAA0101 Interacts with BRCA1 and Regulates Centrosome Number. Molecular Cancer Research. 9(8). 1091–1099. 54 indexed citations

Pilarski, Robert, Julie Stephens, Ryan Noss, James L. Fisher, & T. Prior. (2011). Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan–Riley–Ruvalcaba syndrome clinical features. Journal of Medical Genetics. 48(8). 505–512. 99 indexed citations

10.

Abdel‐Rahman, Mohamed H., Robert Pilarski, James B. Massengill, et al.. (2011). Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition. Melanoma Research. 21(3). 175–179. 16 indexed citations

11.

Abdel‐Rahman, Mohamed H., et al.. (2010). Lack of GNAQ germline mutations in uveal melanoma patients with high risk for hereditary cancer predisposition. Familial Cancer. 10(2). 319–321. 5 indexed citations

12.

Güler, Gülnur, Kay Huebner, Çiğdem Himmetoğlu, et al.. (2009). Fragile histidine triad protein, WW domain‐containing oxidoreductase protein Wwox, and activator protein 2γ expression levels correlate with basal phenotype in breast cancer. Cancer. 115(4). 899–908. 40 indexed citations

13.

Young, S. R., Robert Pilarski, Talia Donenberg, et al.. (2009). The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. BMC Cancer. 9(1). 86–86. 179 indexed citations

14.

Westman, Judith A., Amy K. Ferketich, Steven N. MacEachern, et al.. (2009). Low cancer incidence rates in Ohio Amish. Cancer Causes & Control. 21(1). 69–75. 27 indexed citations

15.

Agrawal, Shipra, et al.. (2006). Distinct Expression Profiles for PTEN Transcript and Its Splice Variants in Cowden Syndrome and Bannayan-Riley-Ruvalcaba Syndrome. The American Journal of Human Genetics. 79(1). 23–30. 34 indexed citations

16.

Pyatt, Robert E., Robert Pilarski, & Thomas W. Prior. (2006). Mutation Screening in Juvenile Polyposis Syndrome. Journal of Molecular Diagnostics. 8(1). 84–88. 26 indexed citations

17.

Pezzolesi, Marcus G., Yan Li, Xiao-Ping Zhou, et al.. (2006). Mutation-Positive and Mutation-Negative Patients with Cowden and Bannayan-Riley-Ruvalcaba Syndromes Associated with Distinct 10q Haplotypes. The American Journal of Human Genetics. 79(5). 923–934. 24 indexed citations

18.

Agrawal, Shipra, Robert Pilarski, & Charis Eng. (2005). Different splicing defects lead to differential effects downstream of the lipid and protein phosphatase activities of PTEN. Human Molecular Genetics. 14(16). 2459–2468. 35 indexed citations

19.

Waite, Kristin, Robert Pilarski, Yunfeng Luo, et al.. (2003). No PTEN protein and altered downstream signaling due to heterozygous germline PTEN mutations in Cowden syndrome. The American Journal of Human Genetics. 73(5). 173. 1 indexed citations

20.

Zhou, Xiao-Ping, Kristin Waite, Robert Pilarski, et al.. (2003). Germline PTEN Promoter Mutations and Deletions in Cowden/Bannayan-Riley-Ruvalcaba Syndrome Result in Aberrant PTEN Protein and Dysregulation of the Phosphoinositol-3-Kinase/Akt Pathway. The American Journal of Human Genetics. 73(2). 404–411. 199 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact